GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t ...

OTC Markets is benefiting from a cyclical tailwind manifested in increased retail trading activity. Find out why OTCM stock is rated a hold.

Over-the-counter medications for sale at a pharmacy. (Photo by: Jeffrey Greenberg/Universal Images Group via Getty Images) Food and Drug Administration Commissioner Marty Makary tweeted last week that ...

Q4 2025 Management View CEO Robert Coulson reported that for the full year 2025, gross revenues grew 13% to over $125 million for the first time in the company’s history, with net revenues up 12%.

Q4 2025 earnings call highlights: guidance, EPS outlook, market share gains, cost cuts, Dermacosmetics sale and 2026 risks—read now.